The global epigenetics market accounted for $555 million in 2016, and is, registering a CAGR of 13.1% from 2017 to 2023. Epigenetics is a stream of genetics that involves the study of cellular and physiological trait variations initiated by external or ecological aspects, which turn genes on and off and affect the cellular ability to read genes without being affected by changes in the genotype Epigenetics results into changes in the organisms’ phenotype rather than the genotype, wherein the underlying DNA or RNA sequence remains unchanged .
Get a Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/1227774?utm_source=wa&utm_medium=Srbh
The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits & assays, instruments, and reagents
Enzymes are further classified into DNA ligases, DNA polymerases, other DNA-modifying enzymes, acetylases, methyltransferases, other protein-modifying enzymes, reverse transcriptase, RNA ligases, and other RNA-modifying enzymes
Kits & assays are further subdivided into bisulfite conversion kits, chip-seq kits, deep sequencing kits, methyltransferase assays, histone assays, immunoprecipitation kits & other epigenetic kits
Based on instruments, the market is further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, and sonicators & other instruments.
Reagents are further divided into antibodies, buffers, histones, magnetic beads, primers, and other epigenetics reagents.
Market Segmentation By Application : Oncology (solid tumors & liquid tumors)and non-oncology (inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications)
Market Segmentation By End User : academic & research institutes, pharmaceutical companies, biotechnology companies, and contract research organizations (CROs).
Market Segmentation By Geography : Analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Get Purchase Discount @ https://www.bigmarketresearch.com/request-for-discount/1227774?utm_source=wa&utm_medium=Srbh
Key Players :
Abcam plc.,Illumina,QIAGEN N.V.,Epizyme, Inc.,New England Biolabs, Inc.,Merck & Co.,,Thermo Fisher Scientific, Inc.,Active Motif,,Diagenode, Inc.,Zymo Research Corporation CHT/BEZEMA Group,Clariant,Bayer AG,Sumitomo Chemicals,Sarex,Lonson Inc.
KEY MARKET BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global epigenetics market and the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on application assists to understand the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Make an inquiry for purchasing this report @ https://www.bigmarketresearch.com/purchase-enquiry/1227774?utm_source=op&utm_medium=Srbh
Big Market Research has a range of research reports from various publishers across the world.
Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for. We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.
Mr. Abhishek Paliwal
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
email [email protected]